In addition, the amount of apo-CP in the mouse serum, measured as the apo-CP/albumin ratio, was not significantly impaired in the WD mice compared to the controls, and it did not change upon treatment with TDMQ20 up to 50 mg/kg/d (Table S4, Figure S1). Here, ALB is linked to Wilson disease.